Mandate

Vinge advises Active Biotech on rights offering

November 24, 2014

Active Biotech AB (publ) (Nasdaq Stockholm) carries out a rights offering of SEK 225 million. Vinge advises Active Biotech.

The Vinge team primarily consists of Erik Sjöman (partner, capital markets & public M&A) and associates Christian Lindhé, Ludvig Frithiof and Madelene Eriksson.

Related

Naval Group signs contract for four defence and intervention frigates (FDI) for the Royal Swedish Navy

Vinge has advised Naval Group in connection with the negotiations with the Swedish Defence Materiel Administration (FMV) for the procurement of four defence and intervention frigates (FDI) for the Swedish Navy. The contract was signed on 31 August 2026 in Stockholm. Naval Group has been selected as a strategic partner by the Swedish Government to rapidly strengthen and modernise its fleet's capabilities.
September 08, 2026

Vinge advises Axcel and Sanviva on the acquisitions of DermaCura and YourRad

Vinge has advised Axcel Elevate I and Sanviva in connection with the acquisitions of DermaCura and YourRad.
September 07, 2026

Vinge advises Revivo Group on the acquisition of Premator

Revivo Group AB has acquired all the shares in Premator AB, the parent company of a group operating in the field of advanced surface treatment with extensive experience in shot blasting, anti-corrosion painting and related services. Operations are conducted in Sweden, Norway and Denmark.
September 03, 2026